@article{article, title  = {{Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT)}},

 publisher = {{Wiley}},

 url = {{}},

 year = {{2023}},

 month = {{2}},

 author = {{Clark A and Thomas S and Hamblin A and Talley P and Kulasekararaj A and Grinfeld J and Speight B and Snape K and McVeigh TP and Snowden JA}},

 doi = {{10.1111/bjh.18682}},

 journal = {{British Journal of Haematology}},

 note = {{Accessed on 2024/12/22}}}